Bessemer Group’s Immunocore IMCR Stock Holding History

Bessemer Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Buy	50 +4	+9%	+$118	﹤0.01%	2409
2026 Q1	$1K	Buy	+46	New	+$1.49K	﹤0.01%	2442

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bessemer Group's IMCR Position: Q2 2026 in Review

Bessemer Group increased its Immunocore (IMCR) stake by 8.7% in Q2 2026, buying an estimated $118 and bringing the position to 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Bessemer Group first reported a position in IMCR in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Bessemer Group held 50 shares of Immunocore worth $2K as of Q2 2026.
Bessemer Group bought 4 Immunocore shares in Q2 2026, an estimated $118.
Immunocore made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2409 holding.
Bessemer Group first reported a position in Immunocore in Q1 2026 and has held it in 2 quarters since.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.